Inspur Made an Appearance in the 2025 Hong Kong International InnoEX
BEIJING,April 16,2025--From April 13th to 16th,2025,Inspur was invited to participate in the 2025 Hong Kong International Innovation and Technology Exhibition (InnoEX). This event focuses on innovativ
Autoliv: Financial Report January - March 2025
STOCKHOLM,April 16,2025-- (NYSE: ALV) (SSE: ALIV.sdb) Q1 2025: Good sales and execution of cost reduction programs
Winners of the ADGHW Innovation Awards 2025 addressed prenatal gene editing,robotic organ transplantation,precision drug delivery,and novel pain treatments
Moatable Reports 2024 Annual Financial Results
PHOENIX,April 17,2025-- Moatable,Inc. (OTC: MTBLY) ("Moatable" or the "Company"),a leading US-based SaaS company,yesterday reported its fourth quarter 2024 and 2024 annual financia
Beijing's Chaoyang district emerges as a magnet for global talent
BEIJING,April 17,2025-- A news report from chinadaily.com.cn： Beijing\'s Chaoyang district is fast becoming the top destination for internationally-educated talent returning to China to pursue innova
British tourists, 46 and 17, dead after being swept to sea in Australia
A third person suffered life-threatening injuries.
Laboratory Services Cooperative Notifies Individuals of Security Incident
SEATTLE,April 11,2025-- Laboratory Services Cooperative (LSC),a non-profit organization based in Seattle,Washington,is encouraging individuals to take precautionary measures to protect their informati
Over 3 million children died from AMR-related infections in 2022, major study shows
A landmark study presented today at ESCMID Global 2025 has revealed that over 3 million children worldwide lost their lives in 2022 due to antimicrobial resistance (AMR)-related infections.
BEIJING,April 14,2025--General Secretary of the Communist Party of China (CPC) Central Committee and Chinese President Xi Jinping will pay a state visit to Vietnam from April 14 to 15,at the invitatio
Chromatin Bioscience Signs Collaboration Agreement with Astellas
EDINBURGH,Scotland,April 14,2025-- Chromatin Bioscience,a leader in the design of synthetic promoters and gene control systems,is pleased to announce a collaboration agreement withAstellas Pharma,a g